Published in Medical Letter on the CDC and FDA, July 26th, 1999
Patricia S. Walker, National Institutes of Health, Bethesda, Maryland, and colleagues performed a study to determine whether immunostimulatory CpG-containing oligodeoxynucleotides (CpG-ODN), known to promote a Th1 immune response, could provide protection from Leishmania infection ("Immunostimulatory Oligodeoxynucleotides Promote Protective Immunity and Provide Systemic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA